Almac Clinical Launches Web-Based Label Approval System
Published: April 5th, 2010
Almac Clinical Services (Craigavon, Northern Ireland) is offering a workflow-based label approval management system (LAS) that gives users full online review, amendment, traceability, and control functionality regardless of geographic location.
The LAS automates the approval process and speeds up the time taken to generate labels for investigational products. It ensures all steps involved in the label approval are easily visible, traceable, and actionable to users. By eliminating the need for reliance on e-mail, fax, and hard copy, the system speeds up the editing process.
The launch coincides with the launch of a new Web-based Shipping Temperature Electronic Monitoring System (STEMS). STEMS equips clinical supply professionals with immediate visibility over all crucial shipment temperature reports. This enables users to make instant decisions 24/7 on their clinical supplies without the need for monitor returns or faxing of results.
The LAS includes multiple reports so users have full traceability for reviews, edits and approval allowing them to identify any bottlenecks in the label approval process and improve the overall efficiency of clinical label generation.
Key features include current status, history, and label life cycle reporting. Label proofs are automatically sent to predefined user groups. Users have instant visibility to the status of all label approval tasks. Automatic email notifications are sent to designated approvers when labels are available. An online PDF-markup Brava! Reader tool is used to clearly specify changes to label design. Automatic notification of ‘late’ tasks.
"We have invested significantly in the development of this new system (LAS) which is the latest in a series of process improvements to remove bottlenecks in the clinical supply chain. This offering to our service portfolio range will be of major interest to our clients within the pharmaceutical and biotech industries who are seeking faster routes to get their drugs to market,” said Paul O’Connor, vice president of quality.
»
- Login or register to post comments
-
- Email this page
Printer-friendly version